Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation

KUN-CHING LEE, WEI-TING CHEN, YU-CHANG LIU, SONG-SHEI LIN and FEI-TING HSU
In Vivo September 2018, 32 (5) 1097-1103; DOI: https://doi.org/10.21873/invivo.11351
KUN-CHING LEE
1Department of Medical Imaging and Radiological Sciences, Central-Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.
2Department of Radiation Oncology, National Yang-Ming University Hospital, Yilan, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEI-TING CHEN
1Department of Medical Imaging and Radiological Sciences, Central-Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.
3Department of Psychiatry, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YU-CHANG LIU
1Department of Medical Imaging and Radiological Sciences, Central-Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.
2Department of Radiation Oncology, National Yang-Ming University Hospital, Yilan, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SONG-SHEI LIN
1Department of Medical Imaging and Radiological Sciences, Central-Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sslin@ctust.edu.tw sakiro920@gmail.com
FEI-TING HSU
4Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C.
5Department of Medical Imaging, Taipei Medical University Hospital, Taipei, Taiwan, R.O.C.
6Research Center of Translational Imaging, College of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C.
7Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sslin@ctust.edu.tw sakiro920@gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Schematic depiction of experimental protocol. Please refer to Materials and Methods section for details. BLI: Bioluminescent imaging, IHC: immunohistochemistry, HE: hematoxylin and eosin.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Effect of amentoflavone on body weight of SK-Hep1/luc2 tumor-bearing mice. Body weight of mice in vehicle-treated and amentoflavone-treated groups was measured on days 0, 2, 4, 6, 8, 10, 12, and 14 after treatment.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Effect of amentoflavone on tumor growth of SK-Hep1/luc2 tumor-bearing mice. During the treatment period, tumor growth of mice was monitored using digital caliper, bioluminescent imaging (BLI), and animal computed tomography. A: Photograph of tumor removed from mice sacrificed on day 14 after treatment. B: Tumor volume was measured with digital caliper. C: Tumor growth was monitored with BLI and photographs of mice are shown. D: Quantification of total photon flux of BLI. E: Images of whole-body computed tomographic scan on day 14 after treatment. Significantly different at ap<0.05 and bp<0.01 compared to the vehicle-treated group.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Effect of amentoflavone on tumor progression-associated proteins modulated by extracellular signal-regulated kinase (ERK)/nuclear factor-ĸB (NF-ĸB) in SK-Hep1/luc2 tumor-bearing mice. Protein levels of phosphorylated (P)ERK, NF-ĸB p65 (Ser536), matrix metallopeptidase 9 (MMP-9), vascular endothelial growth factor (VEGF), cyclin-D1, myeloid leukemia cell differentiation protein (MCL-1), cellular FADD-like IL-1β-converting enzyme-inhibitory protein (C-FLIP), and X-linked inhibitor of apoptosis protein (XIAP) in tumor tissues were investigated by immunohistochemistry. A: Image at magnification of 100×. B: Quantification of protein level. C: Pathological examination of liver tissues obtained from mice sacrificed on day 14 after treatment was evaluated by hematoxylin-eosin staining. aSignificantly different at p<0.01 compared to the vehicle-treated group.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 32, Issue 5
September-October 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation
KUN-CHING LEE, WEI-TING CHEN, YU-CHANG LIU, SONG-SHEI LIN, FEI-TING HSU
In Vivo Sep 2018, 32 (5) 1097-1103; DOI: 10.21873/invivo.11351

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation
KUN-CHING LEE, WEI-TING CHEN, YU-CHANG LIU, SONG-SHEI LIN, FEI-TING HSU
In Vivo Sep 2018, 32 (5) 1097-1103; DOI: 10.21873/invivo.11351
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo
  • Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib
  • Suppression of ERK/NF-{kappa}B Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression In Vivo
  • Google Scholar

More in this TOC Section

  • Association of Matrix Metalloproteinase-7 Genotypes With Nasopharyngeal Carcinoma Risk
  • Age- and Periodontal Disease Independent Correlation of Salivary Amino Acids
  • Activation of Invariant Natural Killer T Cells Enhances Ischemia-Reperfusion Injury in Steatotic Mouse Livers
Show more Experimental Studies

Similar Articles

Keywords

  • Amentoflavone
  • hepatocellular carcinoma
  • extracellular signal-regulated kinase
  • nuclear factor-kappaB
  • bioluminescence imaging
In Vivo

© 2025 In Vivo

Powered by HighWire